Related Experiment Video
Updated: Mar 1, 2026

08:59
Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021
3.2K
Occupational formaldehyde and amyotrophic lateral sclerosis.
Ryan M Seals1, Marianthi-Anna Kioumourtzoglou2, Ole Gredal3
1Department of Epidemiology, Harvard School of Public Health, 677 Huntington Ave, Boston, MA, 02115, USA. rms730@mail.harvard.edu.
European Journal of Epidemiology
|June 7, 2017
Summary
Formaldehyde exposure is linked to an increased risk of amyotrophic lateral sclerosis (ALS). This population study suggests occupational formaldehyde exposure may contribute to ALS development.
Area of Science:
- Neuroscience
- Occupational Health
- Environmental Epidemiology
Background:
- Inconsistent evidence exists regarding the association between formaldehyde exposure and amyotrophic lateral sclerosis (ALS).
- Understanding occupational risk factors for ALS is crucial for public health.
- Formaldehyde is a common industrial chemical with potential neurotoxic effects.
Purpose of the Study:
- To investigate the relationship between occupational formaldehyde exposure and the risk of developing ALS.
- To provide robust epidemiological evidence on formaldehyde and ALS.
- To identify potential environmental contributors to ALS etiology.
Main Methods:
- Population-based case-control study using Danish National Registries.
- Occupational history data from a pension database (since 1964) linked to a job-exposure matrix for formaldehyde exposure estimation.
- Conditional logistic regression analysis matching 3650 ALS cases (1982-2009) to 4 population controls, adjusting for confounders.
Main Results:
- A significant association was found between formaldehyde exposure and an increased rate of ALS.
- Individuals employed in jobs with formaldehyde exposure showed a 1.3-fold increased rate of ALS (95% CI 1.2-1.4).
- Approximately 25% of controls were employed in jobs with potential formaldehyde exposure.
Conclusions:
- Occupational formaldehyde exposure is associated with an elevated risk of amyotrophic lateral sclerosis.
- Employment in formaldehyde-exposed occupations may be a contributing factor to ALS.
- Further research into specific exposure levels and mechanisms is warranted.
More Related Videos
Related Concept Videos
Amyloid Fibrils
12.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.2K
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K

